John H. Beale

John H. Beale

Auto-generated profile, based on publicly available information

John H. Beale

Paul Scherrer Institute, Villigen, Switzerland

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2019 in IUCrJ
Verified
Journal Article
Open access
PDF file
AEAli Ebrahim
Ali Ebrahim
TMTadeo Moreno-Chicano
Tadeo Moreno-Chicano
MAMartin V. Appleby
Martin V. Appleby
ACAmanda K. Chaplin
Amanda K. Chaplin
JBJohn H. Beale
John H. Beale
MHMichael Hough
Michael Hough
An approach is demonstrated to obtain, in a sample- and time-efficient manner, multiple dose-resolved crystal structures from room-temperature protein microcrystals using identical fixed-target supports at both synchrotrons and X-ray free-electron lasers (XFELs). This approach allows direct comparison of dose-resolved serial synchrotron and damage-free XFEL serial femtosecond crystallography structures of radiation-sensitive proteins. Specifically, serial synchrotron structures of a heme peroxidase enzyme reveal that X-ray induced changes occur at far lower doses than those at which diffraction quality is compromised (the Garman limit), consistent with previous studies on the reduction of heme proteins by low X-ray doses. In these structures, a functionally relevant bond length is shown to vary rapidly as a function of absorbed dose, with all room-temperature synchrotron structures exhibiting linear deformation of the active site compared with the XFEL structure. It is demonstrated that extrapolation of dose-dependent synchrotron structures to zero dose can closely approximate the damage-free XFEL structure. This approach is widely applicable to any protein where the crystal structure is altered by the synchrotron X-ray beam and provides a solution to the urgent requirement to determine intact structures of such proteins in a high-throughput and accessible manner.

1 October 2015 in Structure
Verified
Journal Article
Open access
JBJohn H. Beale
John H. Beale
JPJoanne L. Parker
Joanne L. Parker
FSFirdaus Samsudin
Firdaus Samsudin
ABAnne L. Barrett
Anne L. Barrett
ASAnish Senan
Anish Senan
SNSimon Newstead
Simon Newstead
Mammals obtain nitrogen via the uptake of di- and tri-peptides in the gastrointestinal tract through the action of PepT1 and PepT2, which are members of the POT family of proton-coupled oligopeptide transporters. PepT1 and PepT2 also play an important role in drug transport in the human body. Recent crystal structures of bacterial homologs revealed a conserved peptide-binding site and mechanism of transport. However, a key structural difference exists between bacterial and mammalian homologs with only the latter containing a large extracellular domain, the function of which is currently unknown. Here, we present the crystal structure of the extracellular domain from both PepT1 and PepT2 that reveal two immunoglobulin-like folds connected in tandem, providing structural insight into mammalian peptide transport. Functional and biophysical studies demonstrate that these domains interact with the intestinal protease trypsin, suggesting a role in clustering proteolytic activity to the site of peptide transport in eukaryotic cells.

1 December 2023 in Science
Verified
Journal Article
Closed access
NCNina-Eleni Christou
Nina-Eleni Christou
VAVirginia Apostolopoulou
Virginia Apostolopoulou
DMDiogo V. M. Melo
Diogo V. M. Melo
MRMatthias Ruppert
Matthias Ruppert
AFAlisia Fadini
Alisia Fadini
TLThomas J. Lane
Thomas J. Lane
Photolyase is an enzyme that uses light to catalyze DNA repair. To capture the reaction intermediates involved in the enzyme’s catalytic cycle, we conducted a time-resolved crystallography experiment. We found that photolyase traps the excited state of the active cofactor, flavin adenine dinucleotide (FAD), in a highly bent geometry. This excited state performs electron transfer to damaged DNA, inducing repair. We show that the repair reaction, which involves the lysis of two covalent bonds, occurs through a single-bond intermediate. The transformation of the substrate into product crowds the active site and disrupts hydrogen bonds with the enzyme, resulting in stepwise product release, with the 3′ thymine ejected first, followed by the 5′ base.

1 September 2020 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
VPVera Pfanzagl
Vera Pfanzagl
JBJohn H. Beale
John H. Beale
HMHanna Michlits
Hanna Michlits
DSDaniel Schmidt
Daniel Schmidt
TGThomas Gabler
Thomas Gabler
SHStefan Hofbauer
Stefan Hofbauer
Since the advent of protein crystallography, atomic-level macromolecular structures have provided a basis to understand biological function. Enzymologists use detailed structural insights on ligand coordination, interatomic distances and positioning of catalytic amino acids to rationalize the underlying electronic reaction mechanisms. Often the proteins in question catalyze redox reactions using metal cofactors that are explicitly intertwined with their function. In these cases, the exact nature of the coordination sphere and the oxidation state of the metal is of utmost importance. Unfortunately, the redox active nature of metal cofactors makes them especially susceptible to photoreduction, meaning that information obtained by photoreducing X-ray sources about the environment of the cofactor are the least trustworthy part of the structure. In this work we directly compare the kinetics of photoreduction of six different heme protein crystal species at by X-ray radiation. We show that a dose of approximately 40 kGy already yields 50% ferrous iron in a heme protein crystal. We also demonstrate that the kinetics of photoreduction are completely independent from variables unique to the different samples tested. The photoreduction-induced structural rearrangements around the metal cofactors have to be considered when biochemical data of ferric proteins are rationalized by constraints derived from crystal structures of reduced enzymes.

14 November 2019 in Journal of Applied Crystallography
Verified
Journal Article
Open access
PDF file
JBJohn H. Beale
John H. Beale
RBRachel Bolton
Rachel Bolton
SMStephen Marshall
Stephen Marshall
EBEmma V. Beale
Emma V. Beale
SCStephen B. Carr
Stephen B. Carr
RORobin L. Owen
Robin L. Owen
Serial crystallography, at both synchrotron and X-ray free-electron laser light sources, is becoming increasingly popular. However, the tools in the majority of crystallization laboratories are focused on producing large single crystals by vapour diffusion that fit the cryo-cooled paradigm of modern synchrotron crystallography. This paper presents several case studies and some ideas and strategies on how to perform the conversion from a single crystal grown by vapour diffusion to the many thousands of micro-crystals required for modern serial crystallography grown by batch crystallization. These case studies aim to show (i) how vapour diffusion conditions can be converted into batch by optimizing the length of time crystals take to appear; (ii) how an understanding of the crystallization phase diagram can act as a guide when designing batch crystallization protocols; and (iii) an accessible methodology when attempting to scale batch conditions to larger volumes. These methods are needed to minimize the sample preparation gap between standard rotation crystallography and dedicated serial laboratories, ultimately making serial crystallography more accessible to all crystallographers.

17 February 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
MWMaximilian Wranik
Maximilian Wranik
TWTobias Weinert
Tobias Weinert
CSChavdar Slavov
Chavdar Slavov
TMTiziana Masini
Tiziana Masini
AFAntonia Furrer
Antonia Furrer
JSJörg Standfuss
Jörg Standfuss
The binding and release of ligands from their protein targets is central to fundamental biological processes as well as to drug discovery. Photopharmacology introduces chemical triggers that allow the changing of ligand affinities and thus biological activity by light. Insight into the molecular mechanisms of photopharmacology is largely missing because the relevant transitions during the light-triggered reaction cannot be resolved by conventional structural biology. Using time-resolved serial crystallography at a synchrotron and X-ray free-electron laser, we capture the release of the anti-cancer compound azo-combretastatin A4 and the resulting conformational changes in tubulin. Nine structural snapshots from 1 ns to 100 ms complemented by simulations show how cis-to-trans isomerization of the azobenzene bond leads to a switch in ligand affinity, opening of an exit channel, and collapse of the binding pocket upon ligand release. The resulting global backbone rearrangements are related to the action mechanism of microtubule-destabilizing drugs.